Skip to main content

As with many other substances, a patient’s use of marijuana, both medically and recreationally, can impact physical therapy outcomes.

We have a lot yet to learn, and many issues are in flux: State laws and regulations around medical and recreational use are changing, making it imperative to understand what is and isn't permitted in your state. Similarly, FDA Controlled Substance Act classifications around the variety of products derived from cannabis and cannabinoids can be complex, with drug classifications ranging from Schedule I to Schedule V. To date, there is not enough data to make recommendations for the clinical use of topical cannabinoids.

Though our understanding is evolving, information is increasingly available as use becomes more and more common. Here are some resources that can help you gain perspective on the issue.

Log in or create a free account to keep reading.

Join APTA to get unlimited access to content.

You Might Also Like...


Study: Use of Nonopioid Pain Treatment Rises Significantly From 2011 to 2019

Nov 10, 2022

Physical and occupational therapy made significant gains in prevalence for both chronic and post-surgery pain treatment.


Physical Therapy and Pain Management

Oct 1, 2022

Many patients are returning for services after putting physical therapy on hold because of the pandemic. PTs need to be ready to assess and treat.


A Call to Action: Joe Godges Says PTs Need to Expand Their Approach to MSK Pain

Aug 12, 2022

The next APTA Lecture Series event looks at how patients' mental impairments can affect thoughts on pain — and what PTs can do.